Financial Gravity Companies’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Financial Gravity Companies’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$0	Buy	+3	New	+$53	﹤0.01%	1546
2018 Q1	$0	Sell	3 -241	-99%	-$17.1K	﹤0.01%	1696
2017 Q4	$18K	Buy	+244	New	+$20.2K	0.02%	499

Other funds holding LUMO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Gravity Companies's LUMO Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2018: 3 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1546 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in LUMO as recently as Q1 2018.

Financial Gravity Companies first reported a position in LUMO in Q4 2017 and has held it in 3 quarters since. The position peaked at $18K in Q4 2017. 87 funds tracked by Wall St. Rank hold LUMO as of Q4 2018.

Financial Gravity Companies held 3 shares of Lumos Pharma, Inc. Common Stock worth $0 as of Q4 2018.
Lumos Pharma, Inc. Common Stock was a new Financial Gravity Companies position in Q4 2018.
Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1546 holding.
Financial Gravity Companies first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2017 and has held it in 3 quarters since.
Financial Gravity Companies's Lumos Pharma, Inc. Common Stock position peaked at $18K in Q4 2017.
87 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.